STERIS (STE) Stock Forecast & Price Target

STERIS
Bull Case

Here are some ways that investors could benefit from investing in STERIS plc:

• STERIS plc recently reported strong financial performance in its latest earnings release on August 5, 2026, where the company beat analyst expectations by posting earnings per share of $2.59 against a consensus estimate of $2.49, demonstrating robust profitability with a net margin of 13.34% and a return on equity of 14.34%.
• The company has strengthened its appeal to income-focused investors by increasing its quarterly dividend to $0.69 per share, which represents an annualized payout of $2.76 and a dividend yield of 1.33%, supported by a sustainable payout ratio of 33.74% that leaves ample room for future growth.
• Wall Street analysts maintain a positive outlook on the stock, with a consensus rating of Moderate Buy and an average price target of $271.33, which suggests significant upside potential from the current stock price of $208.73 as of September 22, 2026.
• Institutional investor confidence remains high, with 94.69% of the company's stock owned by institutional investors and hedge funds, and recent filings show major funds like Wellington Management Group LLP increasing their holdings by 21.9% in the second quarter.
• STERIS plc is positioned for continued growth with its FY 2027 guidance projecting earnings per share between $11.00 and $11.30, which aligns with the consensus estimate of $11.16 and reflects the company's strong market position in infection prevention and sterilization services.